If basic painkillers barely touch your migraines, that is not a personal failing or a sign you need a higher dose of ibuprofen. It is a clue about what a migraine actually is. Migraine is not a general pain problem that a general pain reliever can mute. It runs on a specific neurological pathway, and triptans were built to act on that pathway. This post explains the mechanism in plain terms, why the timing of the dose decides whether it works, and why painkillers so often fall short.

What a migraine attack is doing

A migraine attack is not happening in your muscles or your sinuses. It runs through the trigeminovascular system, a network involving the trigeminal nerve and the blood vessels around the brain.

During an attack, the trigeminal nerve endings release inflammatory neuropeptides, the best known being calcitonin gene-related peptide (CGRP). These peptides dilate cranial blood vessels and sensitize the nerves that carry pain signals. The result is the throbbing, the light and sound sensitivity and the nausea. The pain is being generated by an active neurological process, not by tissue damage that a painkiller would normally address.

This is why a migraine feels different from a bruise or a strained muscle. It is a different machine, and it needs a different tool.

What triptans actually do

Triptans are selective agonists at two serotonin receptor subtypes, 5-HT1B and 5-HT1D. Those two targets map onto the two halves of the problem.

5-HT1B receptors sit on the dilated cranial blood vessels. Triptan activation here causes those vessels to constrict back toward normal, reversing part of the migraine's vascular component.

5-HT1D receptors sit on the trigeminal nerve terminals. Triptan activation here inhibits the release of CGRP and other neuropeptides, and dampens the transmission of pain signals along the trigeminal pathway.

So a triptan works on both ends: it constricts the vessels that have dilated and it shuts down the neuropeptide release driving the inflammation and pain (American Headache Society). It is acting on the specific biology of the attack, which is exactly what a general painkiller cannot do.

Why timing decides everything

The single most important thing about taking a triptan is taking it early. Triptans work best when the attack is still in its early phase, while the pain is mild and before a process called central sensitization sets in.

Central sensitization is when the pain pathways in the brain become wound up and hyperexcitable, often signaled by allodynia, where even light touch like glasses on your face or hair brushing your scalp starts to hurt. Once that has happened, a triptan is far less likely to abort the attack. The vessels and the peripheral nerves are no longer the whole story; the central pain processing has taken over.

The practical rule is to dose at the first clear sign of a migraine, not to wait and see if it gets bad. Waiting is the most common reason a triptan "did not work." It often did not get its chance.

Why painkillers often fall short

Acetaminophen and NSAIDs work on general pain and inflammation. They can help mild migraines, especially early, and an NSAID like naproxen has a real role. But for moderate to severe migraine they frequently underperform, because they are not acting on the trigeminovascular mechanism at all. They blunt pain perception broadly without touching the neuropeptide release and vascular changes that are generating the attack.

There is a second, worse problem with leaning on painkillers for frequent migraines: medication-overuse headache. Taking acute pain medications too many days a month can convert episodic migraine into a near-daily headache. People who treat frequent migraines with over-the-counter painkillers are at real risk of this, often without knowing it. So the painkiller route can both fail to work well and, used often enough, make the underlying problem worse.

Triptans are first-line for a reason

Triptans are established first-line acute treatment for moderate to severe migraine. Oral sumatriptan and the other triptans give two-hour pain-free rates clearly superior to placebo, and the combination of a triptan with naproxen outperforms either alone. The 2024 American Headache Society guidance elevated CGRP-targeting drugs as first-line preventive therapy, but that did not displace triptans for acute treatment, where they remain first-line (American Headache Society Consensus Statement).

That is the key division. Triptans abort an attack that is happening. Preventives reduce how often attacks come. They are different jobs, and triptans own the acute one.

Who should not take a triptan

Triptans constrict blood vessels, which is the catch. They are contraindicated in people with ischemic heart disease, prior heart attack, coronary vasospasm, uncontrolled high blood pressure, stroke or TIA history, peripheral vascular disease and in hemiplegic or basilar migraine. They also should not be combined with ergot drugs or another triptan within 24 hours. This is why a triptan needs a prescriber who screens your cardiovascular history first, rather than being something to borrow from a friend.

The bottom line

Migraine runs on the trigeminovascular pathway, driven by CGRP release and vessel dilation. Triptans hit that pathway directly through 5-HT1B and 5-HT1D receptors, which is why they work when ordinary painkillers do not. Take them early, at the first sign, before central sensitization sets in. And be aware that leaning on painkillers for frequent attacks can backfire into medication-overuse headache. The right tool, used at the right time, is what changes a migraine day.

Medically reviewed by: [Reviewer name, credentials] — [Date]

If painkillers are not controlling your migraines, a licensed clinician can review your history and discuss whether a triptan is right for you. Start an online visit.

This article is for general education and is not a substitute for personalized medical advice from a licensed clinician.